GSA Capital Partners’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $173K | Sell |
14,977
-32,776
| -69% | -$379K | 0.01% | 1540 |
|
|
2025
Q1 | $417K | Buy |
47,753
+16,831
| +54% | +$147K | 0.04% | 925 |
|
|
2024
Q4 | $444K | Buy |
+30,922
| New | +$444K | 0.03% | 977 |
|
|
2023
Q4 | – | Sell |
-47,664
| Closed | -$1.97M | – | 1942 |
|
|
2023
Q3 | $1.97M | Buy |
47,664
+39,158
| +460% | +$1.62M | 0.17% | 112 |
|
|
2023
Q2 | $475K | Buy |
+8,506
| New | +$475K | 0.05% | 775 |
|
|
2023
Q1 | – | Sell |
-18,550
| Closed | -$676K | – | 1945 |
|
|
2022
Q4 | $676K | Buy |
+18,550
| New | +$676K | 0.08% | 418 |
|
|
2021
Q3 | – | Sell |
-1,798
| Closed | -$352K | – | 1781 |
|
|
2021
Q2 | $352K | Buy |
+1,798
| New | +$352K | 0.04% | 841 |
|
|
2021
Q1 | – | Sell |
-1,888
| Closed | -$267K | – | 1504 |
|
|
2020
Q4 | $267K | Buy |
1,888
+238
| +14% | +$33.7K | 0.04% | 810 |
|
|
2020
Q3 | $206K | Buy |
+1,650
| New | +$206K | 0.03% | 993 |
|